Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography

European Journal of Nuclear Medicine

Volumn 25, Issue 9, 1998, Pages 1248-1254

  Moore, James V ^a   Waller, Michael L ^a   Zhao, Sha ^a   Dodd, Nicholas J F ^a   Acton, Paul D ^b   Jeavons, Alan P ^c   Hastings, David L ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Oxford Positron Systems   (United Kingdom)

Author keywords

Fluorodeoxyglucose; Magnetic resonance; Mammary carcinoma; Photodynamic therapy; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEMATOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HISTOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; TREATMENT OUTCOME; TUMOR NECROSIS;

ANIMALS; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEMATOPORPHYRIN PHOTORADIATION; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031710733     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050292     Document Type: Article

References (30)

1. Moore JV, West CML, Whitehurst C. The biology of photodynamic therapy. Phys Med Biol 1997; 42: 913-935.
2. Marcus SL, Dugan MH. Global status of clinical photodynamic therapy: the registration process for a new therapy. Lasers Surg Med 1992; 12: 318-324.
3. Seminars in Surgical Oncology. Issue 5 (special issue) 1995; 11: 333-376.
4. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 1992; 52: 4914-4921.
5. West DC, Moore JV. Photodynamic therapy and endothelial cells. In: Rubin DB, ed. The radiation biology of the vascular endothelium. Boca Raton: CRC Press; 1998: 231-245.
6. Moore JV, Dodd NJF, Wood B. Proton nuclear magnetic resonance imaging as a predictor of the outcome of photodynamic therapy of tumours. Br J Radiol 1989; 62: 869-870.
7. Fingar VH, Wieman TJ, Doak KW. Changes in tumour interstitial pressure induced by photodynamic therapy. Photochem Photobiol 1991; 53: 763-768.
8. Ceckler TL, Gibson SL, Kennedy SD, Hilf R, Bryant RG. Heterogeneous tumour response to photodynamic therapy assessed by in vivo localised 31P-NMR spectroscopy. Br J Cancer 1991; 63: 916-922.
9. Chapman JD, McPhee MS, Walz N, Chetner MP, Stobbe CC, Soderlind K. Nuclear magnetic resonance spectroscopy and sensitiser-adduct measurements of photodynamic therapy-induced ischaemia in solid tumours. J Natl Cancer Inst 1991; 83: 1650-1659.
10. Dodd NJF, Moore JV, Poppitt DG, Wood B. In vivo magnetic-resonance imaging of the effects of photodynamic therapy. Br J Cancer 1989; 60: 164-167.
11. Dodd NJF, Zhao S, Moore JV. Diffusion-weighted magnetic-resonance imaging in the early detection of tumour response to therapy. Radiol Oncol 1998; 32: 103-108.
12. Musser DA. The effect of photodynamic therapy (PDT) on glucose levels within the SMT-F mouse tumour. Res Commun Chem Pathol Pharmacol 1988; 60: 361-369.
13. Smith TAD, FDG uptake, tumour characteristics and response to therapy; a review. Nucl Med Commun 1998; 19: 97-105.
14. Nagasawa H, Kogure K, Fujiwara T, Itoh M, Ido T. Metabolic disturbances in exo-focal brain areas after cortical stroke studied by positron emission tomography. J Neurol Sci 1994; 123: 147-153.
15. Beller GA. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability. Q J Nucl Med 1996; 40: 55-67.
16. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoural distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl 1995; 36: 1854-1861.
17. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumours after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997; 30: 280-287.
18. 18FDG. In: Faulkner K, ed. Quantitative imaging in oncology. London: British Institute of Radiology; 1996: 9-13.
19. Moore JV. The dynamics of tumour cords in an irradiated mouse mammary carcinoma with a large hypoxic cell component. Jpn J Cancer Res 1988; 79: 236-243.
20. Townsend D, Frey P, Jeavons AP. High Density Avalanche Chamber (HIDAC) positron camera. J Nucl Med 1987; 28: 1554-1562.
21. Clade R, Townsend D, Jeavons AP. Increased sensitivity and field of view for a rotating positron camera. Phys Med Biol 1984; 29: 1421-1432.
22. Colsher JG. Fully three-dimensional positron emission tomography. Phys Med Biol 1980; 25: 103-115.
23. 18F-labelled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med 1977; 18: 990-996.
24. Larson SM, Weiden PL, Grunbaum Z. Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication. J Nucl Med 1981; 22: 875-879.
25. McKee BTA, Hogan MJ, Howse DCN. Compton scattering in a large-aperture positron imaging system. IEEE Trans Med Imaging 1988; 7: 198-202.
26. Rowland SW. Computer implementations of image reconstruction formulas. In: Herman GT, ed. Image reconstruction from projections. Berlin Heidelberg New York: Springer; 1979: 9-78.
27. Liu YH, Hawk RM, Ramprasad S. In vivo relaxation time measurements on a murine tumour model - prolongation of T1 after photodynamic therapy. Magn Reson Imaging 1995; 13: 251-258.
28. 18F] fluorodeoxyglucose PET images for the evaluation of patients with brain tumours. J Comput Assist Tomogr 1997; 213: 183-191.
29. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 1972-1980.
30. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994; 35: 1067-1075.